Has Sankar Chirumamilla, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,420 in general payments to Sankar Chirumamilla, MD across 71 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sankar Chirumamilla, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sankar Chirumamilla, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sankar Chirumamilla, MD

Physical Medicine & Rehabilitation · Pikeville, KYNPI 1124346705

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (55.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by KCI USA, Inc. at 52.2% of the total. Reporting peaked in 2023 at $1,472 and has fallen 83.1% since, to $249 in 2025.

$2,420in general payments, 2019–2025

Across 71 payments — averaging $34.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

KCI USA, Inc.$1K
Gilead$274
AbbVie$219
Dexcom, Inc.$145
AstraZeneca$112
Madrigal Pharmaceuticals$91
plus $314 from 11 others

What the payments were for

Travel & lodging$1,05444%
Food & beverage$1,33155%
Education$351%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
KCI USA, Inc.	7	$1,264
Gilead	18	$274
AbbVie(2 entities)	20	$219
Dexcom, Inc.	4	$145
AstraZeneca(2 entities)	2	$112
Madrigal Pharmaceuticals	1	$91
Johnson & Johnson	5	$71
Abbott	2	$36
Merck	2	$36
GSK	2	$33
Amgen	2	$30
Merz Pharmaceuticals, LLC	1	$24
Boehringer Ingelheim	1	$22
Lilly USA, LLC	1	$18
Takeda Pharmaceuticals U.S.A., Inc.	1	$17
Shionogi Inc	1	$14
Biogen	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,420 in reported general payments places this provider in the 85th percentile of 104 physical medicine & rehabilitation providers in Kentucky.

See all physical medicine & rehabilitation providers in Kentucky →

Medicare billing

Part B allowed, 2024

$92,609

Medicare patients

161

Services billed

1,143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	27	$15,372
Dantrolene Sodium	13	$1,203
Baclofen	38	$754
Pantoprazole Sodium	111	$638
Albuterol Sulfate HfaAlbuterol Sulfate	17	$547
Tizanidine Hcl	54	$344
Sucralfate	13	$316
Levothyroxine Sodium	25	$243
Duloxetine Hcl	17	$199
Atorvastatin Calcium	51	$183
Potassium Chloride	22	$179
Bumetanide	13	$157
Metoprolol Succinate	24	$134
Nitroglycerin	11	$128
Tamsulosin Hcl	25	$119

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Pikeville

Clay GuynnLexington$193K
Lester DuplechanCrestview Hills$28K
Darryl KaelinLouisville$19K
Dhruv PandyaAshland$14K
Raechel PercyLexington$8K
Ushma PatelAshland$7K
Melanie LedfordLexington$6K
Joseph PorterOwensboro$4K
Cecil HollenLexington$4K
Stephen PorterLexington$4K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →